CRITICAL PATH INSTITUTE: Form 990, tax year 2016
View the entire original 990 at ProPublica ↗
- Organization
- CRITICAL PATH INSTITUTE (EIN 20-1991334)
- Tax period
- 2016-07-01 to 2017-06-30
- Filed
- 2018-02-23
- IRS object ID
- 201810549349300546
- Schema version
- 2016v3.0
- Source
- Download XML · Original 990 at ProPublica
Every field in the e-filed return. Faint text is the IRS element name, for citing.
- Return header
- Form 990
- Schedule A
- Schedule B
- Schedule C
- Schedule D
- Schedule F
- Schedule I
- Schedule J
- Schedule O
- Schedule R
Return header ReturnHeader
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return | 2018-02-23T15:04:46-06:00 | ReturnTs |
| Tax Period End | 2017-06-30 | TaxPeriodEndDt |
Preparer Firm PreparerFirmGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Firm EIN | 860683059 | PreparerFirmEIN |
Preparer Firm Name PreparerFirmName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | BEACHFLEISCHMAN PC | BusinessNameLine1Txt |
Preparer US Address PreparerUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 1985 E RIVER ROAD SUITE 201 | AddressLine1Txt |
| City | TUCSON | CityNm |
| State Abbreviation | AZ | StateAbbreviationCd |
| ZIP | 85718 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return Type | 990 | ReturnTypeCd |
| Tax Period Begin | 2016-07-01 | TaxPeriodBeginDt |
Filer Filer
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 201991334 | EIN |
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | CRITICAL PATH INSTITUTE | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Control | CRIT | BusinessNameControlTxt |
| Phone | 5205473440 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 1730 EAST RIVER ROAD NO 200 | AddressLine1Txt |
| City | TUCSON | CityNm |
| State Abbreviation | AZ | StateAbbreviationCd |
| ZIP | 857185898 | ZIPCd |
Business Officer BusinessOfficerGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | STEVEN BROADBENT MBA | PersonNm |
| Person Title | COO | PersonTitleTxt |
| Phone | 5205473440 | PhoneNum |
| Signature | 2018-02-17 | SignatureDt |
| Discuss With Paid Preparer | Yes (1) | DiscussWithPaidPreparerInd |
Preparer Person PreparerPersonGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Person | KAREN K MCCLOSKEY CPA | PreparerPersonNm |
| PTIN | P00099644 | PTIN |
| Phone | 5203214600 | PhoneNum |
Filing Security Information FilingSecurityInformation
IP Address IPAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| I Pv4 Address | 208.87.239.202 | IPv4AddressTxt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| IP | 2018-02-17 | IPDt |
| IP Tm | 15:58:07 | IPTm |
| IP Timezone | US | IPTimezoneCd |
| Filing License Type | P | FilingLicenseTypeCd |
| At Submission Creation Device Id | 23AB17895BAC7DA56F918F3357BB5DF74DD723A1 | AtSubmissionCreationDeviceId |
| At Submission Filing Device Id | EF92F78E7C0E069179DCA9050FD4B48B79C32FEB | AtSubmissionFilingDeviceId |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Tax | 2016 | TaxYr |
| Build TS | 2021-01-29 14:40:06Z | BuildTS |
Form 990 IRS990
| Field | Value | IRS element (for citing) |
|---|---|---|
| Principal Officer | MARTHA BRUMFIELD PHD | PrincipalOfficerNm |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 1730 EAST RIVER ROAD NO 200 | AddressLine1Txt |
| City | TUCSON | CityNm |
| State Abbreviation | AZ | StateAbbreviationCd |
| ZIP | 857185898 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gross Receipts | $15,670,367 | GrossReceiptsAmt |
| Group Return For Affiliates | 0 | GroupReturnForAffiliatesInd |
| Organization501c3 | Yes (X) | Organization501c3Ind |
| Website Address | WWW.C-PATH.ORG | WebsiteAddressTxt |
| Type Of Organization Corp | Yes (X) | TypeOfOrganizationCorpInd |
| Formation | 2004 | FormationYr |
| Legal Domicile State | AZ | LegalDomicileStateCd |
| Activity Or Mission | CREATE AND MANAGE INTERNATIONAL COLLABORATIONS AND DEVELOP NOVEL TOOLS, ENABLING THE FASTER DEVELOPMENT OF SAFER MEDICAL PRODUCTS. | ActivityOrMissionDesc |
| Voting Members Governing Body | 14 | VotingMembersGoverningBodyCnt |
| Voting Members Independent | 13 | VotingMembersIndependentCnt |
| Total Employee | 68 | TotalEmployeeCnt |
| Total Volunteers | 14 | TotalVolunteersCnt |
| Total Gross UBI | $0 | TotalGrossUBIAmt |
| Net Unrelated Bus Txbl Incm | $0 | NetUnrelatedBusTxblIncmAmt |
| PY Contributions Grants | $10,197,464 | PYContributionsGrantsAmt |
| CY Contributions Grants | $10,085,049 | CYContributionsGrantsAmt |
| PY Program Service Revenue | $5,069,034 | PYProgramServiceRevenueAmt |
| CY Program Service Revenue | $5,531,847 | CYProgramServiceRevenueAmt |
| PY Investment Income | $15,089 | PYInvestmentIncomeAmt |
| CY Investment Income | $50,971 | CYInvestmentIncomeAmt |
| PY Other Revenue | $51,912 | PYOtherRevenueAmt |
| CY Other Revenue | $2,500 | CYOtherRevenueAmt |
| PY Total Revenue | $15,333,499 | PYTotalRevenueAmt |
| CY Total Revenue | $15,670,367 | CYTotalRevenueAmt |
| PY Grants And Similar Paid | $2,657,978 | PYGrantsAndSimilarPaidAmt |
| CY Grants And Similar Paid | $1,853,946 | CYGrantsAndSimilarPaidAmt |
| PY Benefits Paid To Members | $0 | PYBenefitsPaidToMembersAmt |
| CY Benefits Paid To Members | $0 | CYBenefitsPaidToMembersAmt |
| PY Salaries Comp Emp Bnft Paid | $6,010,064 | PYSalariesCompEmpBnftPaidAmt |
| CY Salaries Comp Emp Bnft Paid | $7,188,245 | CYSalariesCompEmpBnftPaidAmt |
| PY Total Prof Fndrsng Expns | $0 | PYTotalProfFndrsngExpnsAmt |
| CY Total Prof Fndrsng Expns | $0 | CYTotalProfFndrsngExpnsAmt |
| CY Total Fundraising Expense | $0 | CYTotalFundraisingExpenseAmt |
| PY Other Expenses | $5,997,897 | PYOtherExpensesAmt |
| CY Other Expenses | $6,113,896 | CYOtherExpensesAmt |
| PY Total Expenses | $14,665,939 | PYTotalExpensesAmt |
| CY Total Expenses | $15,156,087 | CYTotalExpensesAmt |
| PY Revenues Less Expenses | $667,560 | PYRevenuesLessExpensesAmt |
| CY Revenues Less Expenses | $514,280 | CYRevenuesLessExpensesAmt |
| Total Assets BOY | $18,234,620 | TotalAssetsBOYAmt |
| Total Assets EOY | $16,508,211 | TotalAssetsEOYAmt |
| Total Liabilities BOY | $12,782,629 | TotalLiabilitiesBOYAmt |
| Total Liabilities EOY | $10,541,940 | TotalLiabilitiesEOYAmt |
| Net Assets Or Fund Balances BOY | $5,451,991 | NetAssetsOrFundBalancesBOYAmt |
| Net Assets Or Fund Balances EOY | $5,966,271 | NetAssetsOrFundBalancesEOYAmt |
| Info In Schedule O Part III | Yes (X) | InfoInScheduleOPartIIIInd |
| Mission | THE CRITICAL PATH INSTITUTE IS A CATALYST IN THE DEVELOPMENT OF NEW APPROACHES THAT ADVANCE MEDICAL INNOVATION AND REGULATORY SCIENCE. THIS IS ACHIEVED BY LEADING TEAMS THAT SHARE DATA, KNOWLEDGE AND EXPERTISE RESULTING IN SOUND, CONSENSUS BASED SCIENCE. | MissionDesc |
| Significant New Program Srvc | 0 | SignificantNewProgramSrvcInd |
| Significant Change | 0 | SignificantChangeInd |
| Expense | $12,569,647 | ExpenseAmt |
| Grant | $1,853,946 | GrantAmt |
| Revenue | $5,531,847 | RevenueAmt |
| Desc | SEE SCHEDULE O | Desc |
| Total Program Service Expenses | $12,569,647 | TotalProgramServiceExpensesAmt |
| Described In Section501c3 | Yes (1) | DescribedInSection501c3Ind |
| Schedule B Required | Yes (1) | ScheduleBRequiredInd |
| Political Campaign Acty | 0 | PoliticalCampaignActyInd |
| Lobbying Activities | Yes (1) | LobbyingActivitiesInd |
| Subject To Proxy Tax | 0 | SubjectToProxyTaxInd |
| Donor Advised Fund | 0 | DonorAdvisedFundInd |
| Conservation Easements | 0 | ConservationEasementsInd |
| Collections Of Art | 0 | CollectionsOfArtInd |
| Credit Counseling | 0 | CreditCounselingInd |
| Temp Or Permanent Endowments | 0 | TempOrPermanentEndowmentsInd |
| Report Land Building Equipment | Yes (1) | ReportLandBuildingEquipmentInd |
| Report Investments Other Sec | 0 | ReportInvestmentsOtherSecInd |
| Report Program Related Invst | 0 | ReportProgramRelatedInvstInd |
| Report Other Assets | 0 | ReportOtherAssetsInd |
| Report Other Liabilities | 0 | ReportOtherLiabilitiesInd |
| Include FIN48 Footnote | Yes (1) | IncludeFIN48FootnoteInd |
| Independent Audit Fincl Stmt | Yes (1) | IndependentAuditFinclStmtInd |
| Consolidated Audit Fincl Stmt | 0 | ConsolidatedAuditFinclStmtInd |
| School Operating | 0 | SchoolOperatingInd |
| Foreign Office | 0 | ForeignOfficeInd |
| Foreign Activities | Yes (1) | ForeignActivitiesInd |
| More Than5000 K To Org | Yes (1) | MoreThan5000KToOrgInd |
| More Than5000 K To Individuals | 0 | MoreThan5000KToIndividualsInd |
| Professional Fundraising | 0 | ProfessionalFundraisingInd |
| Fundraising Activities | 0 | FundraisingActivitiesInd |
| Gaming Activities | 0 | GamingActivitiesInd |
| Operate Hospital | 0 | OperateHospitalInd |
| Grants To Organizations | Yes (1) | GrantsToOrganizationsInd |
| Grants To Individuals | 0 | GrantsToIndividualsInd |
| Schedule J Required | Yes (1) | ScheduleJRequiredInd |
| Tax Exempt Bonds | 0 | TaxExemptBondsInd |
| Engaged In Excess Benefit Trans | 0 | EngagedInExcessBenefitTransInd |
| PY Excess Benefit Trans | 0 | PYExcessBenefitTransInd |
| Loan Outstanding | 0 | LoanOutstandingInd |
| Grant To Related Person | 0 | GrantToRelatedPersonInd |
| Business Rln With Org Mem | 0 | BusinessRlnWithOrgMemInd |
| Business Rln With Fam Mem | 0 | BusinessRlnWithFamMemInd |
| Business Rln With Officer Ent | 0 | BusinessRlnWithOfficerEntInd |
| Deductible Non Cash Contri | 0 | DeductibleNonCashContriInd |
| Deductible Art Contribution | 0 | DeductibleArtContributionInd |
| Terminate Operations | 0 | TerminateOperationsInd |
| Partial Liquidation | 0 | PartialLiquidationInd |
| Disregarded Entity | 0 | DisregardedEntityInd |
| Related Entity | Yes (1) | RelatedEntityInd |
| Related Organization Ctrl Ent | Yes (1) | RelatedOrganizationCtrlEntInd |
| Transaction With Control Ent | 0 | TransactionWithControlEntInd |
| Trnsfr Exmpt Non Chrtbl Rltd Org | 0 | TrnsfrExmptNonChrtblRltdOrgInd |
| Activities Conducted Prtshp | 0 | ActivitiesConductedPrtshpInd |
| Schedule O Required | Yes (1) | ScheduleORequiredInd |
| IRP Document | 30 | IRPDocumentCnt |
| IRP Document W2 G | 0 | IRPDocumentW2GCnt |
| Backup Wthld Compliance | Yes (1) | BackupWthldComplianceInd |
| Employee | 68 | EmployeeCnt |
| Employment Tax Returns Filed | Yes (1) | EmploymentTaxReturnsFiledInd |
| Unrelated Bus Incm Over Limit | 0 | UnrelatedBusIncmOverLimitInd |
| Foreign Financial Account | 0 | ForeignFinancialAccountInd |
| Prohibited Tax Shelter Trans | 0 | ProhibitedTaxShelterTransInd |
| Taxable Party Notification | 0 | TaxablePartyNotificationInd |
| Nondeductible Contributions | 0 | NondeductibleContributionsInd |
| Quid Pro Quo Contributions | 0 | QuidProQuoContributionsInd |
| Form8282 Property Disposed Of | 0 | Form8282PropertyDisposedOfInd |
| Rcv Fnds To Pay Prsnl Bnft Cntrct | 0 | RcvFndsToPayPrsnlBnftCntrctInd |
| Pay Premiums Prsnl Bnft Cntrct | 0 | PayPremiumsPrsnlBnftCntrctInd |
| Indoor Tanning Services | 0 | IndoorTanningServicesInd |
| Info In Schedule O Part VI | Yes (X) | InfoInScheduleOPartVIInd |
| Governing Body Voting Members | 14 | GoverningBodyVotingMembersCnt |
| Independent Voting Member | 13 | IndependentVotingMemberCnt |
| Family Or Business Rln | Yes (1) | FamilyOrBusinessRlnInd |
| Delegation Of Mgmt Duties | 0 | DelegationOfMgmtDutiesInd |
| Change To Org Documents | 0 | ChangeToOrgDocumentsInd |
| Material Diversion Or Misuse | 0 | MaterialDiversionOrMisuseInd |
| Members Or Stockholders | 0 | MembersOrStockholdersInd |
| Election Of Board Members | 0 | ElectionOfBoardMembersInd |
| Decisions Subject To Approva | 0 | DecisionsSubjectToApprovaInd |
| Minutes Of Governing Body | Yes (1) | MinutesOfGoverningBodyInd |
| Minutes Of Committees | Yes (1) | MinutesOfCommitteesInd |
| Officer Mailing Address | 0 | OfficerMailingAddressInd |
| Local Chapters | 0 | LocalChaptersInd |
| Form990 Provided To Gvrn Body | Yes (1) | Form990ProvidedToGvrnBodyInd |
| Conflict Of Interest Policy | Yes (1) | ConflictOfInterestPolicyInd |
| Annual Disclosure Covered Prsn | Yes (1) | AnnualDisclosureCoveredPrsnInd |
| Regular Monitoring Enfrc | Yes (1) | RegularMonitoringEnfrcInd |
| Whistleblower Policy | Yes (1) | WhistleblowerPolicyInd |
| Document Retention Policy | Yes (1) | DocumentRetentionPolicyInd |
| Compensation Process CEO | Yes (1) | CompensationProcessCEOInd |
| Compensation Process Other | Yes (1) | CompensationProcessOtherInd |
| Investment In Joint Venture | 0 | InvestmentInJointVentureInd |
| States Where Copy Of Return Is Fld | AZ | StatesWhereCopyOfReturnIsFldCd |
| Upon Request | Yes (X) | UponRequestInd |
Books In Care Of Detail BooksInCareOfDetail
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | STEVE BROADBENT | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Phone | 5206478382 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 1730 EAST RIVER ROAD SUITE 200 | AddressLine1Txt |
| City | TUCSON | CityNm |
| State Abbreviation | AZ | StateAbbreviationCd |
| ZIP | 857185898 | ZIPCd |
Form990 Part VII Section A Form990PartVIISectionAGrp (21 entries)
| TitleTitleTxt | Average Hours Per WeekAverageHoursPerWeekRt | Individual Trustee Or DirectorIndividualTrusteeOrDirectorInd | Reportable Comp From OrgReportableCompFromOrgAmt | Reportable Comp From Rltd OrgReportableCompFromRltdOrgAmt | Other CompensationOtherCompensationAmt | OfficerOfficerInd | Highest Compensated EmployeeHighestCompensatedEmployeeInd |
|---|---|---|---|---|---|---|---|
| D CRAIG BRATER MD | |||||||
| BOARD MEMBER | 1.00 | Yes (X) | $0 | $0 | $0 | ||
| THE HONORABLE JAMES C GREENWOOD | |||||||
| BOARD MEMBER | 1.00 | Yes (X) | $0 | $0 | $0 | ||
| MICHAEL KASSER MBA PHD | |||||||
| BOARD MEMBER | 1.00 | Yes (X) | $0 | $0 | $0 | ||
| SHAUN A KIRKPATRICK MA | |||||||
| BOARD MEMBER | 1.00 | Yes (X) | $0 | $0 | $0 | ||
| RICHARD T MYERS JR | |||||||
| BOARD MEMBER | 1.00 | Yes (X) | $0 | $0 | $0 | ||
| CINDY PARSEGHIAN MBA | |||||||
| BOARD MEMBER | 1.00 | Yes (X) | $0 | $0 | $0 | ||
| ALASTAIR JJ WOOD MB CHB | |||||||
| BOARD MEMBER | 1.00 | Yes (X) | $0 | $0 | $0 | ||
| PETER BARTON HUTT LLB LLM | |||||||
| BOARD MEMBER | 1.00 | Yes (X) | $0 | $0 | $0 | ||
| ALAN G LEVIN MS CPA | |||||||
| BOARD MEMBER | 1.00 | Yes (X) | $0 | $0 | $0 | ||
| PAULA OLSIEWSKI PHD | |||||||
| BOARD MEMBER | 1.00 | Yes (X) | $0 | $0 | $0 | ||
| JEFFREY E JACOB SM | |||||||
| DEPUTY CHAIR | 1.00 | Yes (X) | $0 | $0 | $0 | ||
| M WAINWRIGHT FISHBURN JR | |||||||
| VICE CHAIRMAN | 1.00 | Yes (X) | $0 | $0 | $0 | Yes (X) | |
| TIMOTHY R FRANSON MD | |||||||
| CHAIRMAN OF THE BOARD | 1.00 | Yes (X) | $0 | $0 | $0 | Yes (X) | |
| MARTHA A BRUMFIELD PHD | |||||||
| CHIEF EXECUTIVE OFFICER & PRESIDENT | 40.00 | Yes (X) | $296,577 | $0 | $31,011 | Yes (X) | |
| STEVEN T BROADBENT MBA | |||||||
| CHIEF OPERATING OFFICER & TREASURER | 40.00 | $187,021 | $0 | $26,155 | Yes (X) | ||
| LEWIS BARBIERI | |||||||
| SECRETARY | 40.00 | $113,208 | $0 | $18,707 | Yes (X) | ||
| LYNN D HUDSON PHD | |||||||
| CHIEF SCIENCE OFFICER | 40.00 | $195,453 | $0 | $17,522 | Yes (X) | ||
| JOHN-MICHAEL SAUER PHD | |||||||
| EXECUTIVE DIRECTOR PSTC | 40.00 | $184,460 | $0 | $21,850 | Yes (X) | ||
| STEPHEN J COONS PHD | |||||||
| EXECUTIVE DIRECTOR PROC | 40.00 | $179,348 | $0 | $20,915 | Yes (X) | ||
| STEVE ARNERIC PHD | |||||||
| EXECUTIVE DIRECTOR | 40.00 | $170,534 | $0 | $21,847 | Yes (X) | ||
| DIANE STEPHENSON PHD | |||||||
| EXECUTIVE DIRECTOR CPP | 40.00 | $164,406 | $0 | $24,104 | Yes (X) | ||
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Reportable Comp From Org | $1,491,007 | TotalReportableCompFromOrgAmt |
| Tot Reportable Comp Rltd Org | $0 | TotReportableCompRltdOrgAmt |
| Total Other Compensation | $182,111 | TotalOtherCompensationAmt |
| Indiv Rcvd Greater Than100 K | 12 | IndivRcvdGreaterThan100KCnt |
| Former Ofcr Employees Listed | 0 | FormerOfcrEmployeesListedInd |
| Total Comp Greater Than150 K | Yes (1) | TotalCompGreaterThan150KInd |
| Compensation From Other Srcs | 0 | CompensationFromOtherSrcsInd |
Contractor Compensation ContractorCompensationGrp (5 entries)
| Address Line1ContractorAddress/USAddress/AddressLine1Txt | CityContractorAddress/USAddress/CityNm | State AbbreviationContractorAddress/USAddress/StateAbbreviationCd | ZIPContractorAddress/USAddress/ZIPCd | ServicesServicesDesc | CompensationCompensationAmt | Address Line1ContractorAddress/ForeignAddress/AddressLine1Txt | CityContractorAddress/ForeignAddress/CityNm | CountryContractorAddress/ForeignAddress/CountryCd | Foreign PostalContractorAddress/ForeignAddress/ForeignPostalCd |
|---|---|---|---|---|---|---|---|---|---|
| RESEARCH TRIANGLE INC | |||||||||
| 200 PARK OFFICES DRIVE | RESEARCH TRIANGLE PARK | NC | 27709 | RESEARCH | $714,099 | ||||
| PREMIER RESEARCH INTERNATIONAL | |||||||||
| PO BOX 347566 | PITTSBURGH | PA | 15251 | RESEARCH | $264,558 | ||||
| ADELPHI VALUES | |||||||||
| RESEARCH | $256,193 | ADELPHI MILL BOLLINGTON | CHESIRE | UK | SK105JB | ||||
| PACIFIC BIOMARKERS | |||||||||
| 45 ELLIOTT AVENUE WEST SUITE 300 | SEATTLE | WA | 98119 | RESEARCH SUPPORT SERVICES | $220,968 | ||||
| EPHIBIAN | |||||||||
| 3180 N SWAN ROAD | TUCSON | AZ | 85712 | IT SERVICES | $211,600 | ||||
| Field | Value | IRS element (for citing) |
|---|---|---|
| Cntrct Rcvd Greater Than100 K | 10 | CntrctRcvdGreaterThan100KCnt |
| Government Grants | $2,824,994 | GovernmentGrantsAmt |
| All Other Contributions | $7,260,055 | AllOtherContributionsAmt |
| Total Contributions | $10,085,049 | TotalContributionsAmt |
Program Service Revenue ProgramServiceRevenueGrp (2 entries)
| DescDesc | BusinessBusinessCd | Total Revenue ColumnTotalRevenueColumnAmt | Related Or Exempt Func IncomeRelatedOrExemptFuncIncomeAmt |
|---|---|---|---|
| RESEARCH SUPPORT FEES | 541700 | $5,403,668 | $5,403,668 |
| OTHER REVENUE | 900099 | $128,179 | $128,179 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Program Service Revenue | $5,531,847 | TotalProgramServiceRevenueAmt |
Investment Income InvestmentIncomeGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $45,971 | TotalRevenueColumnAmt |
| Exclusion | $45,971 | ExclusionAmt |
Gross Rents GrossRentsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Real | $2,500 | RealAmt |
Less Rental Expenses LessRentalExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Real | $0 | RealAmt |
Rental Income Or Loss RentalIncomeOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Real | $2,500 | RealAmt |
Net Rental Income Or Loss NetRentalIncomeOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $2,500 | TotalRevenueColumnAmt |
| Exclusion | $2,500 | ExclusionAmt |
Gross Amount Sales Assets GrossAmountSalesAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other | $5,000 | OtherAmt |
Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other | $0 | OtherAmt |
Gain Or Loss GainOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other | $5,000 | OtherAmt |
Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $5,000 | TotalRevenueColumnAmt |
| Exclusion | $5,000 | ExclusionAmt |
Total Revenue TotalRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $15,670,367 | TotalRevenueColumnAmt |
| Related Or Exempt Func Income | $5,531,847 | RelatedOrExemptFuncIncomeAmt |
| Unrelated Business Revenue | $0 | UnrelatedBusinessRevenueAmt |
| Exclusion | $53,471 | ExclusionAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Info In Schedule O Part IX | Yes (X) | InfoInScheduleOPartIXInd |
Grants To Domestic Orgs GrantsToDomesticOrgsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,842,400 | TotalAmt |
| Program Services | $1,842,400 | ProgramServicesAmt |
Foreign Grants ForeignGrantsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $11,546 | TotalAmt |
| Program Services | $11,546 | ProgramServicesAmt |
Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $681,676 | TotalAmt |
| Program Services | $231,086 | ProgramServicesAmt |
| Management And General | $450,590 | ManagementAndGeneralAmt |
Other Salaries And Wages OtherSalariesAndWagesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $5,222,962 | TotalAmt |
| Program Services | $3,971,879 | ProgramServicesAmt |
| Management And General | $1,251,083 | ManagementAndGeneralAmt |
Pension Plan Contributions PensionPlanContributionsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $377,873 | TotalAmt |
| Program Services | $284,412 | ProgramServicesAmt |
| Management And General | $93,461 | ManagementAndGeneralAmt |
Other Employee Benefits OtherEmployeeBenefitsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $493,365 | TotalAmt |
| Program Services | $353,031 | ProgramServicesAmt |
| Management And General | $140,334 | ManagementAndGeneralAmt |
Payroll Taxes PayrollTaxesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $412,369 | TotalAmt |
| Program Services | $292,947 | ProgramServicesAmt |
| Management And General | $119,422 | ManagementAndGeneralAmt |
Fees For Services Legal FeesForServicesLegalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $103,386 | TotalAmt |
| Program Services | $102,629 | ProgramServicesAmt |
| Management And General | $757 | ManagementAndGeneralAmt |
Fees For Services Accounting FeesForServicesAccountingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $125,608 | TotalAmt |
| Program Services | $98,153 | ProgramServicesAmt |
| Management And General | $27,455 | ManagementAndGeneralAmt |
Fees For Services Lobbying FeesForServicesLobbyingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $60,193 | TotalAmt |
| Program Services | $59,258 | ProgramServicesAmt |
| Management And General | $935 | ManagementAndGeneralAmt |
Fees For Services Other FeesForServicesOtherGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $3,296,740 | TotalAmt |
| Program Services | $3,245,512 | ProgramServicesAmt |
| Management And General | $51,228 | ManagementAndGeneralAmt |
Advertising AdvertisingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $196,911 | TotalAmt |
| Program Services | $155,096 | ProgramServicesAmt |
| Management And General | $41,815 | ManagementAndGeneralAmt |
Office Expenses OfficeExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $270,536 | TotalAmt |
| Program Services | $231,256 | ProgramServicesAmt |
| Management And General | $39,280 | ManagementAndGeneralAmt |
Information Technology InformationTechnologyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $376,444 | TotalAmt |
| Program Services | $328,596 | ProgramServicesAmt |
| Management And General | $47,848 | ManagementAndGeneralAmt |
Occupancy OccupancyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $514,007 | TotalAmt |
| Program Services | $263,468 | ProgramServicesAmt |
| Management And General | $250,539 | ManagementAndGeneralAmt |
Travel TravelGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $475,046 | TotalAmt |
| Program Services | $451,235 | ProgramServicesAmt |
| Management And General | $23,811 | ManagementAndGeneralAmt |
Conferences Meetings ConferencesMeetingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $533,142 | TotalAmt |
| Program Services | $522,197 | ProgramServicesAmt |
| Management And General | $10,945 | ManagementAndGeneralAmt |
Depreciation Depletion DepreciationDepletionGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $52,848 | TotalAmt |
| Program Services | $37,543 | ProgramServicesAmt |
| Management And General | $15,305 | ManagementAndGeneralAmt |
Insurance InsuranceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $72,767 | TotalAmt |
| Program Services | $56,102 | ProgramServicesAmt |
| Management And General | $16,665 | ManagementAndGeneralAmt |
Other Expenses OtherExpensesGrp (2 entries)
| DescDesc | TotalTotalAmt | Program ServicesProgramServicesAmt | Management And GeneralManagementAndGeneralAmt |
|---|---|---|---|
| DUES AND SUBSCRIPTIONS | $27,987 | $25,190 | $2,797 |
| MISCELLANEOUS | $8,281 | $6,111 | $2,170 |
Total Functional Expenses TotalFunctionalExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $15,156,087 | TotalAmt |
| Program Services | $12,569,647 | ProgramServicesAmt |
| Management And General | $2,586,440 | ManagementAndGeneralAmt |
| Fundraising | $0 | FundraisingAmt |
Cash Non Interest Bearing CashNonInterestBearingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $4,084,148 | BOYAmt |
| EOY | $1,969,152 | EOYAmt |
Savings And Temp Cash Invst SavingsAndTempCashInvstGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $8,406,753 | BOYAmt |
| EOY | $5,994,076 | EOYAmt |
Pledges And Grants Receivable PledgesAndGrantsReceivableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $327,557 | BOYAmt |
| EOY | $1,212,619 | EOYAmt |
Accounts Receivable AccountsReceivableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $1,023,373 | BOYAmt |
| EOY | $400,363 | EOYAmt |
Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $42,542 | BOYAmt |
| EOY | $159,773 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Land Bldg Equip Cost Or Other Bss | $732,850 | LandBldgEquipCostOrOtherBssAmt |
| Land Bldg Equip Accum Deprec | $659,220 | LandBldgEquipAccumDeprecAmt |
Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $86,511 | BOYAmt |
| EOY | $73,630 | EOYAmt |
Investments Pub Traded Sec InvestmentsPubTradedSecGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $4,248,265 | BOYAmt |
| EOY | $6,674,273 | EOYAmt |
Other Assets Total OtherAssetsTotalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $15,471 | BOYAmt |
| EOY | $24,325 | EOYAmt |
Total Assets TotalAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $18,234,620 | BOYAmt |
| EOY | $16,508,211 | EOYAmt |
Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $632,632 | BOYAmt |
| EOY | $753,078 | EOYAmt |
Deferred Revenue DeferredRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $12,149,997 | BOYAmt |
| EOY | $9,788,862 | EOYAmt |
Total Liabilities TotalLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $12,782,629 | BOYAmt |
| EOY | $10,541,940 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Organization Follows SFAS117 | Yes (X) | OrganizationFollowsSFAS117Ind |
Unrestricted Net Assets UnrestrictedNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $5,451,991 | BOYAmt |
| EOY | $5,966,271 | EOYAmt |
Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $5,451,991 | BOYAmt |
| EOY | $5,966,271 | EOYAmt |
Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $18,234,620 | BOYAmt |
| EOY | $16,508,211 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Reconcilation Revenue Expnss | $514,280 | ReconcilationRevenueExpnssAmt |
| Other Changes In Net Assets | $0 | OtherChangesInNetAssetsAmt |
| Method Of Accounting Accrual | Yes (X) | MethodOfAccountingAccrualInd |
| Accountant Compile Or Review | 0 | AccountantCompileOrReviewInd |
| FS Audited | Yes (1) | FSAuditedInd |
FS Audited Basis FSAuditedBasisGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Separate Basis Fincl Stmt | Yes (X) | SeparateBasisFinclStmtInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Audit Committee | Yes (1) | AuditCommitteeInd |
| Federal Grant Audit Required | Yes (1) | FederalGrantAuditRequiredInd |
| Federal Grant Audit Performed | Yes (1) | FederalGrantAuditPerformedInd |
Schedule A IRS990ScheduleA
| Field | Value | IRS element (for citing) |
|---|---|---|
| Public Organization170 | Yes (X) | PublicOrganization170Ind |
Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $5,915,630 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $5,370,782 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $10,269,811 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $10,197,464 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $10,085,049 | CurrentTaxYearAmt |
| Total | $41,838,736 | TotalAmt |
Total Calendar Year170 TotalCalendarYear170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $5,915,630 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $5,370,782 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $10,269,811 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $10,197,464 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $10,085,049 | CurrentTaxYearAmt |
| Total | $41,838,736 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Substantial Contributors Tot | $16,583,869 | SubstantialContributorsTotAmt |
| Public Support Total170 | $25,254,867 | PublicSupportTotal170Amt |
Gross Investment Income170 GrossInvestmentIncome170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $21,279 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $70,230 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $82,059 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $80,580 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $48,471 | CurrentTaxYearAmt |
| Total | $302,619 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Support | $42,141,355 | TotalSupportAmt |
| Gross Receipts Rltd Activities | $20,301,825 | GrossReceiptsRltdActivitiesAmt |
| Public Support CY170 | 0.59930 | PublicSupportCY170Pct |
| Public Support PY170 | 0.67610 | PublicSupportPY170Pct |
| Thirty Thr Pct Suprt Tests CY170 | Yes (X) | ThirtyThrPctSuprtTestsCY170Ind |
Schedule B IRS990ScheduleB
Contributor Information ContributorInformationGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Contributor | RESTRICTED | ContributorNum |
Contributor Business Name ContributorBusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | RESTRICTED | BusinessNameLine1 |
Contributor US Address ContributorUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | RESTRICTED | AddressLine1 |
| Address Line2 | RESTRICTED | AddressLine2 |
| City | RESTRICTED | City |
| State | RESTRICTED | State |
| ZIP Code | RESTRICTED | ZIPCode |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Contributions | RESTRICTED | TotalContributionsAmt |
Schedule C IRS990ScheduleC
Total Direct Lobbying TotalDirectLobbyingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Filing Organizations Total | $61,348 | FilingOrganizationsTotalAmt |
Total Lobbying Expend TotalLobbyingExpendGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Filing Organizations Total | $61,348 | FilingOrganizationsTotalAmt |
Other Exempt Purpose Expend OtherExemptPurposeExpendGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Filing Organizations Total | $15,134,932 | FilingOrganizationsTotalAmt |
Total Exempt Purpose Expend TotalExemptPurposeExpendGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Filing Organizations Total | $15,196,280 | FilingOrganizationsTotalAmt |
Lobbying Nontaxable Amount LobbyingNontaxableAmountGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Filing Organizations Total | $909,814 | FilingOrganizationsTotalAmt |
Grassroots Nontaxable GrassrootsNontaxableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Filing Organizations Total | $227,454 | FilingOrganizationsTotalAmt |
Tot Lbbyng Grassroot Mns Non Tx TotLbbyngGrassrootMnsNonTxGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Filing Organizations Total | $0 | FilingOrganizationsTotalAmt |
Tot Lbby Expend Mns Lbbyng Non Tx TotLbbyExpendMnsLbbyngNonTxGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Filing Organizations Total | $0 | FilingOrganizationsTotalAmt |
Avg Lobbying Nontaxable Amount AvgLobbyingNontaxableAmountGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Year Minus3 | $551,743 | CurrentYearMinus3Amt |
| Current Year Minus2 | $809,246 | CurrentYearMinus2Amt |
| Current Year Minus1 | $883,297 | CurrentYearMinus1Amt |
| Current Year | $909,814 | CurrentYearAmt |
| Total | $3,154,100 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Lobbying Ceiling | $4,731,150 | LobbyingCeilingAmt |
Avg Total Lobbying Expend AvgTotalLobbyingExpendGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Year Minus3 | $60,221 | CurrentYearMinus3Amt |
| Current Year Minus2 | $67,262 | CurrentYearMinus2Amt |
| Current Year Minus1 | $11,731 | CurrentYearMinus1Amt |
| Current Year | $61,348 | CurrentYearAmt |
| Total | $200,562 | TotalAmt |
Avg Grassroots Nontaxable AvgGrassrootsNontaxableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Year Minus3 | $137,936 | CurrentYearMinus3Amt |
| Current Year Minus2 | $202,312 | CurrentYearMinus2Amt |
| Current Year Minus1 | $220,824 | CurrentYearMinus1Amt |
| Current Year | $227,454 | CurrentYearAmt |
| Total | $788,526 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grassroots Ceiling | $1,182,789 | GrassrootsCeilingAmt |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | PART II-A, LINE 1B | FormAndLineReferenceDesc |
| Explanation | C-PATH SPENT A MINOR AMOUNT OF FUNDS ON LOBBYING IN FYE 06/30/2017. GENERALLY, C-PATH DOES NOT LOBBY FOR OR AGAINST ANY SPECIFIC LEGISLATION. C-PATH EXPENDS SOME TIME AND RESOURCES TO EDUCATE MEMBERS OF CONGRESS IN THE AREA OF DRUG DEVELOPMENT. | ExplanationTxt |
Schedule D IRS990ScheduleD
Leasehold Improvements LeaseholdImprovementsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $42,014 | OtherCostOrOtherBasisAmt |
| Depreciation | $32,361 | DepreciationAmt |
| Book Value | $9,653 | BookValueAmt |
Equipment EquipmentGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $179,139 | OtherCostOrOtherBasisAmt |
| Depreciation | $179,139 | DepreciationAmt |
| Book Value | $0 | BookValueAmt |
Other Land Buildings OtherLandBuildingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $511,697 | OtherCostOrOtherBasisAmt |
| Depreciation | $447,720 | DepreciationAmt |
| Book Value | $63,977 | BookValueAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Book Value Land Buildings | $73,630 | TotalBookValueLandBuildingsAmt |
| Footnote Text | Yes (X) | FootnoteTextInd |
| Total Rev Etc Audited Fincl Stmt | $15,670,367 | TotalRevEtcAuditedFinclStmtAmt |
| Revenue Not Reported | $0 | RevenueNotReportedAmt |
| Revenue Subtotal | $15,670,367 | RevenueSubtotalAmt |
| Revenue Not Reported Fincl Stmt | $0 | RevenueNotReportedFinclStmtAmt |
| Total Revenue Per Form990 | $15,670,367 | TotalRevenuePerForm990Amt |
| Tot Expns Etc Audited Fincl Stmt | $15,156,087 | TotExpnsEtcAuditedFinclStmtAmt |
| Expenses Not Reported | $0 | ExpensesNotReportedAmt |
| Expenses Subtotal | $15,156,087 | ExpensesSubtotalAmt |
| Expenses Not Rpt Fincl Stmt | $0 | ExpensesNotRptFinclStmtAmt |
| Total Expenses Per Form990 | $15,156,087 | TotalExpensesPerForm990Amt |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | PART X, LINE 2: | FormAndLineReferenceDesc |
| Explanation | FINANCIAL STATEMENT FIN 48 (ASC 740) FOOTNOTE: C-PATH IS EXEMPT FROM INCOME TAXES UNDER BOTH FEDERAL (INTERNAL REVENUE CODE SECTION 501(C)(3)) AND STATE INCOME TAX LAWS, AND IS CLASSIFIED AS OTHER THAN A PRIVATE FOUNDATION. ACCORDINGLY, NO PROVISION FOR FEDERAL AND STATE INCOME TAXES IS MADE IN THE FINANCIAL STATEMENTS. INCOME FROM CERTAIN ACTIVITIES NOT DIRECTLY RELATED TO C-PATH'S TAX-EXEMPT PURPOSE, HOWEVER, MAY BE SUBJECT TO TAXATION AS UNRELATED BUSINESS TAXABLE INCOME (UBTI). GAAP REQUIRES MANAGEMENT TO PERFORM AN EVALUATION OF ALL TAX POSITIONS TAKEN OR EXPECTED TO BE TAKEN IN THE COURSE OF PREPARING C-PATH'S TAX RETURNS TO DETERMINE WHETHER THE TAX POSITIONS MEET A "MORE LIKELY THAN NOT" STANDARD OF BEING SUSTAINED UNDER EXAMINATION BY THE APPLICABLE TAXING AUTHORITIES. THIS EVALUATION IS REQUIRED TO BE PERFORMED FOR ALL OPEN TAX YEARS, AS DEFINED BY THE VARIOUS STATUTES OF LIMITATIONS, FOR FEDERAL AND STATE PURPOSES. C-PATH IS REQUIRED TO FILE INFORMATIONAL RETURNS FOR FEDERAL AND STATE PURPOSES AND, IF IT HAS UBTI, FEDERAL AND STATE INCOME TAX RETURNS. MANAGEMENT HAS PERFORMED ITS EVALUATION OF TAX POSITIONS TAKEN ON ALL OPEN TAX RETURNS AND HAS DETERMINED THAT THERE WERE NO POSITIONS TAKEN THAT DO NOT MEET THE "MORE LIKELY THAN NOT" STANDARD. SHOULD C-PATH EVER BE SUBJECT TO PENALTIES AND INTEREST ASSESSED BY VARIOUS TAXING AUTHORITIES, THEY WOULD BE CLASSIFIED AS MANAGEMENT AND GENERAL EXPENSES. | ExplanationTxt |
Schedule F IRS990ScheduleF
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grant Records Maintained | Yes (1) | GrantRecordsMaintainedInd |
Account Activities Outside US AccountActivitiesOutsideUSGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Region | EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM | RegionTxt |
| Offices | 0 | OfficesCnt |
| Employee | 0 | EmployeeCnt |
| Type Of Activities Conducted | GRANTS TO RECIPIENTS LOCATED IN REGION | TypeOfActivitiesConductedTxt |
| Specific Services Provided | CLINICAL RESEARCH | SpecificServicesProvidedTxt |
| Region Total Expenditures | $11,546 | RegionTotalExpendituresAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Subtotal Offices | 0 | SubtotalOfficesCnt |
| Subtotal Employees | 0 | SubtotalEmployeesCnt |
| Continutation Total Office | 0 | ContinutationTotalOfficeCnt |
| Continutation Total Employee | 0 | ContinutationTotalEmployeeCnt |
| Total Office | 0 | TotalOfficeCnt |
| Total Employee | 0 | TotalEmployeeCnt |
| Subtotal Spent | $11,546 | SubtotalSpentAmt |
| Continuation Spent | $0 | ContinuationSpentAmt |
| Total Spent | $11,546 | TotalSpentAmt |
Grants To Org Outside US GrantsToOrgOutsideUSGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Region | EUROPE (INCLUDING ICELAND & GREENLAND) | RegionTxt |
| Purpose Of Grant | CLINICAL RESEARCH | PurposeOfGrantTxt |
| Cash Grant | $11,546 | CashGrantAmt |
| Manner Of Cash Disbursement | WIRE TRANSFER | MannerOfCashDisbursementTxt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Other Org | 1 | TotalOtherOrgCnt |
| Transfer To Foreign Corp | 0 | TransferToForeignCorpInd |
| Interest In Foreign Trust | 0 | InterestInForeignTrustInd |
| Foreign Corp Ownership | Yes (1) | ForeignCorpOwnershipInd |
| Passive Foreign Investmest Co | 0 | PassiveForeignInvestmestCoInd |
| Foreign Partnership | 0 | ForeignPartnershipInd |
| Boycott Countries | 0 | BoycottCountriesInd |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | PART I, LINE 2: | FormAndLineReferenceDesc |
| Explanation | CRITICAL PATH INSTITUTE ENTERS INTO SUBAWARD AGREEMENTS WITH SUBRECIPIENTS AND REVIEWS PROGRESS DELIVERABLES AND COSTS. | ExplanationTxt |
Schedule I IRS990ScheduleI
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grant Records Maintained | Yes (1) | GrantRecordsMaintainedInd |
Recipient Table RecipientTable (6 entries)
| Address Line1USAddress/AddressLine1Txt | Address Line2USAddress/AddressLine2Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd | Recipient EINRecipientEIN | IRC SectionIRCSectionDesc | Cash GrantCashGrantAmt | Purpose Of GrantPurposeOfGrantTxt |
|---|---|---|---|---|---|---|---|---|
| BAYLOR RESEARCH INSTITUTE | ||||||||
| 1950 N STEMMONS FREEWAY SUITE 5010 | LOCKBOX 846275 | DALLAS | TX | 75207 | 751921898 | 501(C)(3) | $1,327,338 | DEVELOP A HOLLOW FIBER MODEL FOR TUBERCULOSIS RESEARCH |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | ||||||||
| 1855 FOLSOM STREET BOX 0897 | SAN FRANCISCO | CA | 94143 | 946036493 | STATE OF CALIFORNIA | $430,802 | DEVELOP A DISEASE PROGRESSION MODEL FOR TUBERCULOSIS | |
| UNIVERSITY OF FLORIDA | ||||||||
| PO BOX 113001 | GAINSVILLE | FL | 32611 | 596002052 | STATE OF FLORIDA | $15,000 | DEVELOP A POPULATION PHARMACOKINETIC/PHARMACODYNAMIC (PK/PD) MODEL FOR TUBERCULOSIS | |
| CLINICAL DATA INTERCHANGE STANDARDS CONSORTIUM | ||||||||
| PO BOX 2068 | ROUND ROCK | TX | 78680 | 043503931 | 501(C)(3) | $28,615 | DEVELOP CLINICAL DATA STANDARDS | |
| COLORADO STATE UNIVERSITY | ||||||||
| 6003 CAMPUS DELIVERY | FORT COLLINS | CO | 80523 | 846000545 | STATE OF COLORADO | $8,504 | DEVELOP COMPUTER MODELS FOR TUBERCULOSIS | |
| JOHN HOPKINS UNIVERSITY | ||||||||
| 3910 KESWICK ROAD NO N4327B | BALTIMORE | MD | 21211 | 520595110 | 501(C)(3) | $32,141 | DEVELOP COMPUTER MODELS FOR TUBERCULOSIS | |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total501c3 Org | 6 | Total501c3OrgCnt |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | PART I, LINE 2: | FormAndLineReferenceDesc |
| Explanation | CRITICAL PATH INSTITUTE ENTERS INTO SUBAWARD AGREEMENTS WITH SUBRECIPIENTS AND REVIEWS PROGRESS DELIVERABLES AND COSTS. | ExplanationTxt |
Schedule J IRS990ScheduleJ
| Field | Value | IRS element (for citing) |
|---|---|---|
| Compensation Committee | Yes (X) | CompensationCommitteeInd |
| Form990 Of Other Organizations | Yes (X) | Form990OfOtherOrganizationsInd |
| Written Employment Contract | Yes (X) | WrittenEmploymentContractInd |
| Compensation Survey | Yes (X) | CompensationSurveyInd |
| Board Or Committee Approval | Yes (X) | BoardOrCommitteeApprovalInd |
| Severance Payment | 0 | SeverancePaymentInd |
| Supplemental Nonqual Rtr Plan | 0 | SupplementalNonqualRtrPlanInd |
| Equity Based Comp Arrngm | 0 | EquityBasedCompArrngmInd |
| Comp Based On Revenue Of Flng Org | 0 | CompBasedOnRevenueOfFlngOrgInd |
| Comp Bsd On Rev Related Orgs | 0 | CompBsdOnRevRelatedOrgsInd |
| Comp Bsd Net Earns Flng Org | 0 | CompBsdNetEarnsFlngOrgInd |
| Comp Bsd Net Earns Rltd Orgs | 0 | CompBsdNetEarnsRltdOrgsInd |
| Any Non Fixed Payments | 0 | AnyNonFixedPaymentsInd |
| Initial Contract Exception | 0 | InitialContractExceptionInd |
Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (7 entries)
| TitleTitleTxt | Base Compensation Filing OrgBaseCompensationFilingOrgAmt | Compensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmt | Bonus Filing OrganizationBonusFilingOrganizationAmount | Bonus Related OrganizationsBonusRelatedOrganizationsAmt | Other Compensation Filing OrgOtherCompensationFilingOrgAmt | Other Compensation Rltd OrgsOtherCompensationRltdOrgsAmt | Deferred Compensation Flng OrgDeferredCompensationFlngOrgAmt | Deferred Comp Rltd OrgsDeferredCompRltdOrgsAmt | Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmt | Nontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmt | Total Compensation Filing OrgTotalCompensationFilingOrgAmt | Total Compensation Rltd OrgsTotalCompensationRltdOrgsAmt | Comp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmt | Comp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MARTHA A BRUMFIELD PHD | ||||||||||||||
| CHIEF EXECUTIVE OFFICER & PRESIDENT | $296,577 | $0 | $0 | $0 | $0 | $0 | $24,000 | $0 | $7,011 | $0 | $327,588 | $0 | $0 | $0 |
| STEVEN T BROADBENT MBA | ||||||||||||||
| CHIEF OPERATING OFFICER & TREASURER | $187,021 | $0 | $0 | $0 | $0 | $0 | $15,290 | $0 | $10,865 | $0 | $213,176 | $0 | $0 | $0 |
| LYNN D HUDSON PHD | ||||||||||||||
| CHIEF SCIENCE OFFICER | $195,453 | $0 | $0 | $0 | $0 | $0 | $15,180 | $0 | $2,342 | $0 | $212,975 | $0 | $0 | $0 |
| JOHN-MICHAEL SAUER PHD | ||||||||||||||
| EXECUTIVE DIRECTOR PSTC | $184,460 | $0 | $0 | $0 | $0 | $0 | $14,998 | $0 | $6,852 | $0 | $206,310 | $0 | $0 | $0 |
| STEPHEN J COONS PHD | ||||||||||||||
| EXECUTIVE DIRECTOR PROC | $179,348 | $0 | $0 | $0 | $0 | $0 | $14,270 | $0 | $6,645 | $0 | $200,263 | $0 | $0 | $0 |
| STEVE ARNERIC PHD | ||||||||||||||
| EXECUTIVE DIRECTOR | $170,534 | $0 | $0 | $0 | $0 | $0 | $11,162 | $0 | $10,685 | $0 | $192,381 | $0 | $0 | $0 |
| DIANE STEPHENSON PHD | ||||||||||||||
| EXECUTIVE DIRECTOR CPP | $164,406 | $0 | $0 | $0 | $0 | $0 | $13,301 | $0 | $10,803 | $0 | $188,510 | $0 | $0 | $0 |
Schedule O IRS990ScheduleO
Supplemental Information Detail SupplementalInformationDetail (8 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| FORM 990, PART III, LINE 4A, PROGRAM SERVICE ACCOMPLISHMENTS | THE CRITICAL PATH INSTITUTE (C-PATH) IS AN INDEPENDENT, NON-PROFIT ORGANIZATION UNIQUELY DEDICATED TO IMPLEMENTING THE FDA'S CRITICAL PATH INITIATIVE BY CREATING COLLABORATIONS AMONG REGULATORS (SCIENTISTS FROM THE FDA AND EMA), THE REGULATED MEDICAL PRODUCT INDUSTRY, ACADEMIA, PATIENT GROUPS, AND OTHER ORGANIZATIONS THAT ADVANCE MEDICAL INNOVATION THROUGH THE DEVELOPMENT OF TOOLS AND METHODS BASED UPON SOUND, CONSENSUS-BASED SCIENCE. THE ACCOMPLISHMENTS FOR THIS FISCAL YEAR REPORT INCLUDE: THE COALITION AGAINST MAJOR DISEASES DEVELOPS TOOLS AND NOVEL METHODOLOGIES TO ACCELERATE PROGRESS IN THE PREVENTION, TREATMENT AND CURE OF MAJOR NEURODEGENERATIVE DISEASES FOCUSING ON ALZHEIMER'S DISEASE. THIS YEAR'S ACCOMPLISHMENTS INCLUDE: DEVELOPED AN ADDENDUM TO THE INFORMED CONSENT FORM DEVELOPED LAST YEAR THAT WILL ENABLE BROADER SHARING OF PATIENT DATA AND SPECIMENS FOR FUTURE RESEARCH; OBTAINED REGULATORY AGREEMENT FOR THE STATISTICAL ANALYSIS APPROACH FOR THE HIPPOCAMPAL VOLUME BIOMARKER QUALIFICATION EFFORT. THE FULL QUALIFICATION PACKAGE SHOULD BE SUBMITTED IN EARLY 2018. HELD WORKSHOPS ON THE USE OF BIOMETRIC MONITORING DEVICES IN CLINICAL TRIALS AND ASSOCIATED DATA STANDARDS. PUBLISHED TWO JOURNAL ARTICLES. THE COALITION FOR ACCELERATING STANDARDS AND THERAPIES IS AN INITIATIVE TO ACCELERATE CLINICAL RESEARCH AND MEDICAL PRODUCT DEVELOPMENT BY CREATING AND MAINTAINING DATA STANDARDS, TOOLS, AND METHODS FOR CONDUCTING RESEARCH IN THERAPEUTIC AREAS THAT ARE IMPORTANT TO PUBLIC HEALTH. CFAST IS A PARTNERSHIP BETWEEN THE CLINICAL DATA INTERCHANGE STANDARDS CONSORTIUM (CDISC) AND THE CRITICAL PATH INSTITUTE (C-PATH). THIS YEAR THE CONSORTIUM RECEIVED THREE FDA GRANTS AND BEGAN WORK TO DEVELOP DATA STANDARDS FOR HIV, CLOSTRIDIUM DIFFICILE-ASSOCIATED DIARRHEA, AND ONE FOR MEDICAL COUNTERMEASURE STUDIES UNDER THE ANIMAL RULE; PUBLISHED CDISC STANDARDS ON KIDNEY TRANSPLANT, RHEUMATOID ARTHRITIS, MAJOR DEPRESSIVE DISORDER, EBOLA, DIABETIC KIDNEY DISEASE AND MALARIA STANDARDS, AND CARDIOVASCULAR IMAGING; POSTED A STANDARD FOR DUCHENE MUSCULAR DYSTROPHY FOR PUBLIC REVIEW. THE CRITICAL PATH FOR PARKINSON'S GOALS ARE TO DEVELOP QUANTITATIVE MODEL-BASED TOOLS TO ACCELERATE THE TREATMENT OF PARKINSON'S DISEASE, ESPECIALLY FOR THOSE INDIVIDUALS EXPERIENCING THE FIRST CLINICAL SIGNS OF MOTOR SYMPTOM ONSET. THEIR ACCOMPLISHMENTS THIS YEAR INCLUDE: FOUR NEW PARKINSON'S CLINICAL TRIAL DATASETS HAVE BEEN ADDED TO THE DATABASE; SUBMITTED A LETTER OF INTENT AND FULL QUALIFICATION PACKAGE TO EMA FOR THE QUALIFICATION OF MOLECULAR NEUROIMAGING OF THE DOPAMINE TRANSPORTER(DAT) AS A PROGNOSTIC BIOMARKER FOR ENRICHMENT IN TRIALS FOR EARLY PARKINSON'S DISEASE; RECEIVED A LETTER OF SUPPORT FROM THE EMA FOR THE USE OF DAT IMAGING AS AN ENRICHMENT BIOMARKER FOR PD CLINICAL TRIALS. THE MISSION OF THE CRITICAL PATH TO TB DRUG REGIMENS INITIATIVE IS TO ACCELERATE THE DEVELOPMENT OF NOVEL TB DRUG REGIMENS THAT ARE SAFER, SHORTER, AND MORE EFFICACIOUS THAN THE CURRENT STANDARD OF CARE. THEIR MISSION EXPANDED TO ACCELERATE THE DEVELOPMENT OF A CLINICALLY USEFUL IN VITRO RAPID DRUG SUSCEPTIBILITY ASSAY TO SUPPORT TB REGIMEN DEVELOPMENT AND DEPLOYMENT. THEIR ACCOMPLISHMENTS THIS YEAR INCLUDE: SUBMITTED INPUT TO THE FDA DRAFT GUIDANCE ON INFECTIOUS DISEASE NEXT GENERATION SEQUENCING BASED DIAGNOSTIC DEVICES; MET WITH THE EMA ABOUT CPTR'S PHYSIOLOGICALLY BASED TB-INFECTED LUNG MODEL; FORMED A NEW PARTNERSHIP WITH TGEN NORTH/NAU TO DEVELOP AN AZ-BASED SEQUENCING AND DATA PLATFORM COE FOR WHOLE GENOME SEQUENCING OF M. TUBERCULOSIS AND CONTRIBUTE TO THE RESEQTB PLATFORM. THIS WORK IS SUPPORTED BY THE BMGF SEQUENCING SUPPLEMENT GRANT AWARDED TO C-PATH. CPTR IS IN DISCUSSION WITH IMI-PREDICT-TB TO TRANSFER AND HOST THEIR CLINICAL TRIAL DATA REPOSITORY AS THEIR PROGRAM SUNSETS IN EARLY 2018. CPTR IS PARTNERING WITH COMMONWEALTH INFORMATICS TO COLLABORATE ON A COMMONWEALTH CLINICAL DATA ANALYTICS (CCDA) PILOT PROJECT. CPTR HAD A CRITICAL PATH INNOVATION MEETING ON CPTR'S LIPOARABINOMANNAN (LAM) BASED BIOMARKER. A LETTER OF INTENT WAS SUBMITTED TO THE FDA TO START THE PROCESS TO QUALIFY THE BIOMARKER. THE DATA COLLABORATION CENTER IS A CENTER WITHIN C-PATH TO ENABLE MULTIPLE ORGANIZATIONS TO WORK TOGETHER IN A NEUTRAL SETTING AND SHARE CLINICAL DATA IN ORDER TO OPTIMIZE ITS VALUE IN CREATING NEW INSIGHTS AND TOOLS THAT ACCELERATE DRUG DEVELOPMENT IN AREAS WITH UNMET MEDICAL NEEDS. THE DCC SUPPORTS DATA SHARING PROJECTS ALIGNED WITH SPECIFIC C-PATH CONSORTIA AS WELL AS DATA SHARING INITIATIVES THAT ARE INDEPENDENT OF C-PATH CONSORTIA. ITS ACCOMPLISHMENTS THIS YEAR INCLUDE: REMAPPED PARKINSON'S AND DUCHENNE CLINICAL TRIAL DATASETS AND INCLUDED THEM IN THEIR RESPECTIVE DATABASES ACCESSIBLE BY CONSORTIUM MEMBERS; MADE THE TB-ALLIANCE CLINICAL TRIAL DATASETS AVAILABLE TO EXTERNAL QUALIFIED RESEARCHER; DEVELOPED AN INTERACTIVE INTERFACE FOR THE TB PLATFORM; BEGAN DATA CURATION ACTIVITIES FOR THE NEW TYPE 1 DIABETES CONSORTIUM. THE DUCHENNE REGULATORY SCIENCE CONSORTIUM'S GOAL IS TO SUPPORT COLLABORATIVE RESEARCH AND REGULATORY QUALIFICATION OF NEW DRUG DEVELOPMENT TOOLS FOR DUCHENNE MUSCULAR DYSTROPHY, TO ENABLE THE EARLIEST POSSIBLE PATIENT ACCESS TO NEW TREATMENTS. THEIR ACCOMPLISHMENTS THIS YEAR INCLUDE: ACQUIRED SEVERAL ADDITIONAL CLINICAL TRIAL DATASETS FOR INCLUSION IN ITS DATABASE; COMPLETED A NEW DRAFT CDISC DATA STANDARD THAT IS IN PUBLIC REVIEW; DEVELOPED PROPOSED FORMAT FOR DISEASE PROGRESSION MODEL TO BE PRESENTED TO REGULATORS. THE GOAL OF THE ELECTRONIC PATIENT-REPORTED OUTCOME CONSORTIUM IS TO ADVANCE THE SCIENCE OF CLINICAL TRIAL ENDPOINT ASSESSMENT BY COLLABORATIVELY SUPPORTING AND CONDUCTING RESEARCH, DESIGNING AND DELIVERING EDUCATIONAL OPPORTUNITIES, AND DEVELOPING AND DISSEMINATING BEST PRACTICE RECOMMENDATIONS FOR ELECTRONIC COLLECTION OF CLINICAL OUTCOME DATA. THEIR ACCOMPLISHMENTS THIS YEAR INCLUDE: INITIATED A PROJECT ENTITLED: COMPARABILITY OF PROVISIONED DEVICE VS BRING-YOUR-OWN-DEVICE IN SUBJECTS WITH COPD; WORKED WITH THE PRO CONSORTIUM TO DEVELOP A QUESTIONNAIRE ENTITLED, "BARRIERS TO ADOPTION OF ELECTRONIC DATA COLLECTION OF CLINICAL OUTCOME ASSESSMENTS IN CLINICAL TRIALS" THAT WAS SENT TO INDUSTRY MEMBERS. C-PATH INITIATED A PROJECT IN PARTNERSHIP WITH CHDI FOUNDATION TO FORM A NEW CONSORTIUM AND WORK ON DRUG DEVELOPMENT TOOLS FOR HUNTINGTON'S DISEASE. THIS YEAR C-PATH LED THE EFFORT TO DEVELOP A NEW CDISC DATA STANDARD FOR HUNTINGTON'S DISEASE. INVENTORIES OF EXISTING CLINICAL TRIAL DATASETS AND DISEASE MODELS WERE COMPILED TO INFORM A DATA AGGREGATION PLAN. A KICKOFF MEETING IS PLANNED FOR NOVEMBER OF 2017. AT THE REQUEST OF THE FDA, C-PATH FORMED AN INTERNATIONAL NEONATAL CONSORTIUM (INC). THE PURPOSE OF THE CONSORTIUM IS TO ACCELERATE THE DEVELOPMENT OF SAFE AND EFFECTIVE THERAPIES FOR NEONATES. INC ENGAGES THE GLOBAL NEONATAL COMMUNITY - FAMILIES, NEONATAL NURSES, ACADEMIC SCIENTISTS, REGULATORS, PHARMACEUTICAL INVESTIGATORS, ADVOCACY ORGANIZATIONS, AND FUNDERS - TO FOCUS ON THE NEEDS OF THE NEONATE. THIS PAST YEAR INC PROVIDED INPUT TO NICHD FOR INFORMATION OF PRIORITIES IN PEDIATRIC THERAPEUTICS; PUBLISHED SEVERAL MANUSCRIPTS; WORKED TO DEVELOP A GRADING CRITERIA FOR ADVERSE EVENT SEVERITY; EXPANDED THEIR SCOPE TO INCLUDE RETINOPATHY OF PREMATURITY, NECROTIZING ENTEROCOLITIS, AND HEMODYNAMIC ADAPTATION. THE MULTIPLE SCLEROSIS OUTCOME ASSESSMENTS CONSORTIUM HAS A GOAL TO OBTAIN REGULATORY QUALIFICATION OF AN IMPROVED CLINICAL OUTCOME ASSESSMENT INSTRUMENT AS A PRIMARY ENDPOINT IN CLINICAL TRIALS OF MULTIPLE SCLEROSIS (MS) THERAPIES. THEIR ACCOMPLISHMENTS INCLUDE: EFFORTS CONTINUE TO QUALIFY NEW ENDPOINTS FOR CLINICAL TRIALS IN MS; FINAL QUALIFICATION PACKAGES SHOULD BE SUBMITTED TO BOTH THE FDA AND EMA LATER IN 2017; FIVE NEW ARTICLES WERE PUBLISHED; THE PLACEBO ARM DATA WITHIN THE MS DATABASE HAS BEEN MADE AVAILABLE TO QUALIFIED EXTERNAL RESEARCHERS. THE POLYCYSTIC KIDNEY DISEASE OUTCOMES CONSORTIUM HAS DEVELOPED AND OBTAINED REGULATORY QUALIFICATION FROM THE U.S. FOOD AND DRUG ADMINISTRATION (FDA) AND THE EUROPEAN MEDICINES AGENCY (EMA) OF TOTAL KIDNEY VOLUME (TKV) AS A PROGNOSTIC BIOMARKER FOR USE IN CLINICAL TRIALS FOR NEW THERAPIES FOR AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD). THE CONSORTIUM CONTINUES TO EXPLORE ALTERNATE CLINICAL ENDPOINTS, INCLUDING A COMPOSITE ENDPOINT, INNOVATIVE CLINICAL TRIAL DESIGNS, AND REGULATORY PATHWAYS TO HELP EXPEDITE NEW THERAPIES IN PKD. THE FDA HAS COMMUNICATED THAT TKV IS A "REASONABLY LIKELY SURROGATE," WHICH MAKES IT ELIGIBLE FOR AN ACCELERATED APPROVAL PROCESS AT THE FDA. SIX NEW COMPANIES ARE NOW WORKING TO DEVELOP THERAPIES FOR THIS DISEASE. |
| FORM 990, PART III, LINE 4A | THE PATIENT-REPORTED OUTCOME CONSORTIUM HAS A GOAL TO ESTABLISH AND MAINTAIN A COLLABORATIVE FRAMEWORK WITH APPROPRIATE STAKEHOLDERS FOR THE QUALIFICATION OF PATIENT-REPORTED OUTCOME (PRO) INSTRUMENTS AND OTHER CLINICAL OUTCOME ASSESSMENT (COA) TOOLS THAT WILL BE MADE AVAILABLE FOR USE IN CLINICAL TRIALS WHERE COA-BASED ENDPOINTS ARE USED TO SUPPORT PRODUCT LABELING CLAIMS. THE NON-SMALL CELL LUNG CANCER WORKING GROUP COMPLETED ITS QUANTITATIVE PILOT STUDY AND SUBMITTED THE REPORT TO THE FDA. WITH POSITIVE FEEDBACK FROM THE FDA, PROC IS WORKING ON A PERFORMANCE OUTCOME INSTRUMENT TO ASSESS COGNITIVE IMPAIRMENT IN CLINICAL TRIALS FOR MILD COGNITIVE IMPAIRMENT DUE TO ALZHEIMER'S DISEASE; SUBMITTED THE DEPRESSION QUANTITATIVE PILOT STUDY REPORT AND DATA TO FDA FOR REVIEW; INITIATED AN EFFORT TO DEVELOP A PATIENT-REPORTED MEASURE TO ASSESS FATIGUE IN PATIENTS WITH RHEUMATOID ARTHRITIS; SUBMITTED THE ASTHMA QUANTITATIVE PILOT STUDY REPORT AND STUDY DATA TO FDA; PUBLISHED EIGHT ARTICLES; QUALIFICATION BRIEFING PACKAGES WERE SUBMITTED FOR DEPRESSION AND NON-SMALL CELL LUNG CANCER FOR FDA REVIEW. THE PREDICTIVE SAFETY TESTING CONSORTIUM HAS A GOAL TO BRING TOGETHER PHARMACEUTICAL COMPANIES TO SHARE AND VALIDATE INNOVATIVE SAFETY TESTING METHODS UNDER ADVISEMENT OF THE U.S. FOOD AND DRUG ADMINISTRATION (FDA), EUROPEAN MEDICINES AGENCY (EMA), AND JAPAN'S PHARMACEUTICALS AND MEDICAL DEVICES AGENCY (PMDA). CURRENTLY PSTC IS FOCUSED ON DEVELOPING AND OBTAINING REGULATORY QUALIFICATION OF IMPROVED CLINICAL SAFETY BIOMARKERS FOR USE IN DRUG DEVELOPMENT. THIS YEAR THE CONSORTIUM: CO-HOSTED THE DRUG INDUCED LIVER INJURY WORKSHOP; RECEIVED LETTERS OF SUPPORT FOR LIVER, KIDNEY, AND VASCULAR INJURY SAFETY BIOMARKERS FROM THE FDA AND EMA; HELD A SERIES OF WEBINARS ON BILE SALT EXPORT PUMP INHIBITION; SUBMITTED A QUALIFICATION BRIEFING PACKAGE OF GLUTAMATE DEHYDROGENASE AS A SPECIFIC BIOMARKER OF DRUG-INDUCED LIVER INJURY, AND HELD AN ADVICE AND CONSULTATION MEETING WITH THE FDA; HELD A CRITICAL PATH INNOVATION MEETING WITH THE FDA TO DISCUSS A RESEARCH PLAN FOR THE QUALIFICATION OF TRANSLATIONAL DRUG-INDUCED PANCREATIC INJURY SAFETY BIOMARKERS. THE PEDIATRIC TRIALS CONSORTIUM ACCOMPLISHED ITS GOAL OF ESTABLISHING A NEW, INDEPENDENT NON-PROFIT ORGANIZATION TO SUPPORT AND ADVANCE RESEARCH AND EDUCATION ON INNOVATIVE PEDIATRIC TREATMENTS. THE NEW INSTITUTE FOR ADVANCED CLINICAL TRIALS FOR CHILDREN SERVES AS A NEUTRAL FORUM FOR PUBLIC-PRIVATE COLLABORATION IN ADDRESSING COMMON CHALLENGES IN PEDIATRIC TRIALS TO HELP DEMYSTIFY THE STUDIES. IT WILL ALSO ASSIST IN OPTIMIZING STUDY DESIGNS, PROTOCOLS, BEST PRACTICES, TRAINING, AND ENGAGEMENT OF PATIENTS AND PARENTS. TWO NEW CONSORTIA WERE INITIATED THIS YEAR. THE FIRST IS FOCUSING ON QUALIFYING ISLET AUTOIMMUNITY ANTIBODIES AS PROGNOSTIC BIOMARKERS TO BE USED IN THE DEVELOPMENT OF THERAPIES FOR THE TREATMENT, AND ULTIMATELY, THE PREVENTION, OF TYPE 1 DIABETES. THE SECOND IS WORKING TO IDENTIFY MECHANISMS AND DRUG DEVELOPMENT TOOLS TO ACCELERATE DRUG DISCOVERY FOR TRANSPLANT PATIENTS, THROUGH THE COLLABORATIVE INVOLVEMENT OF KEY STAKEHOLDERS IN THE FIELD. THE CONSORTIUM IS INITIALLY FOCUSING ON KIDNEY TRANSPLANT, BUT MAY EXPAND TO OTHER SOLID ORGAN TRANSPLANTS IN THE FUTURE. |
| FORM 990, PART VI, SECTION A, LINE 2 | MIKE KASSER AND JEFF JACOB HAVE A BUSINESS RELATIONSHIP. PETER HUTT AND JEFF JACOB HAVE A BUSINESS RELATIONSHIP. WAIN FISHBURN AND JEFF JACOB HAVE A BUSINESS RELATIONSHIP. |
| FORM 990, PART VI, SECTION B, LINE 11B | FORM 990 IS PREPARED BY AN EXTERNAL CPA FIRM USING INFORMATION PROVIDED BY THE ORGANIZATION. THE FORM IS REVIEWED BY THE ORGANIZATION'S COMPTROLLER, COO, PRESIDENT/CEO, AN OUTSIDE CPA, THE BOARD AUDIT, FINANCE, AND RISK COMMITTEE, AND THE BOARD OF DIRECTORS PRIOR TO BEING FINALIZED. |
| FORM 990, PART VI, SECTION B, LINE 12C | ALL MEMBERS OF THE BOARD OF DIRECTORS AND ALL OFFICERS OF THE ORGANIZATION ARE REQUIRED TO FILL OUT A CONFLICT OF INTEREST FORM ANNUALLY. THE RESULTS ARE COMPILED AND REVIEWED BY THE BOARD'S AUDIT, FINANCE, AND RISK COMMITTEE. ANY ACTUAL OR PERCEIVED CONFLICTS THAT HAVE THE POTENTIAL TO BIAS ANY DISCUSSIONS OR DECISIONS BY THE BOARD ARE DISCUSSED BY THE BOARD. ANY DIRECTOR WITH A REAL OR POTENTIAL CONFLICT WILL RECUSE THEMSELVES FROM ANY DISCUSSION OR DECISION WHERE THE CONFLICT HAS A BEARING. |
| FORM 990, PART VI, SECTION B, LINE 15 | A BOARD OF DIRECTORS COMPENSATION COMMITTEE MEETS AND REVIEWS EXECUTIVE COMPENSATION ANNUALLY. EVERY FEW YEARS THE COMMITTEE SEEKS AN INDEPENDENT COMPENSATION CONSULTING ORGANIZATION. AFTER THE CONSULTING ORGANIZATION HAS BEEN RETAINED, THE COMPENSATION COMMITTEE RECEIVES THE CONSULTANT'S EXECUTIVE COMPENSATION REVIEWS AND RECOMMENDATIONS. THIS INFORMATION IS THEN USED AS A BASIS FOR THE COMPENSATION COMMITTEE'S RECOMMENDATION TO THE BOARD OF DIRECTORS. THE LAST INDEPENDENT COMPENSATION SURVEY WAS CONDUCTED FOR THE CEO IN AUGUST 2011. THE CEO'S SALARY HAS REMAINED CONSTANT SINCE THE TIME OF HER HIRE. AN OVERALL SALARY PROGRAM FOR EMPLOYEES, WHICH IS DEVELOPED BASED ON SALARY SURVEY INFORMATION, MUST BE APPROVED BY THE BOARD OF DIRECTORS COMPENSATION COMMITTEE BEFORE IMPLEMENTATION. ALL EMPLOYEE SALARY INCREASES MUST BE APPROVED BY THE PRESIDENT/CEO. |
| FORM 990, PART VI, SECTION C, LINE 19 | ARTICLES OF INCORPORATION CAN BE FOUND ON THE ARIZONA CORPORATION COMMISSION WEBSITE. THE CONFLICT OF INTEREST POLICY AND THE FINANCIAL STATEMENTS (VIA THE ANNUAL REPORT) ARE POSTED ON THE INSTITUTE'S WEBSITE. |
| FORM 990, PART IX, LINE 11G | RESEARCH SUPPORT SERVICES: PROGRAM SERVICE EXPENSES 1,924,899. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 1,924,899. CONSULTING: PROGRAM SERVICE EXPENSES 665,528. MANAGEMENT AND GENERAL EXPENSES 23,996. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 689,524. OTHER PROFESSIONAL FEES: PROGRAM SERVICE EXPENSES 655,085. MANAGEMENT AND GENERAL EXPENSES 27,232. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 682,317. |
Schedule R IRS990ScheduleR
Id Related Tax Exempt Org IdRelatedTaxExemptOrgGrp (2 entries)
| Address Line1USAddress/AddressLine1Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd | EINEIN | Primary ActivitiesPrimaryActivitiesTxt | Legal Domicile StateLegalDomicileStateCd | Exempt Code SectionExemptCodeSectionTxt | Public Charity StatusPublicCharityStatusTxt | Business Name Line1DirectControllingEntityName/BusinessNameLine1Txt | Controlled OrganizationControlledOrganizationInd | Address Line1ForeignAddress/AddressLine1Txt | CityForeignAddress/CityNm | CountryForeignAddress/CountryCd | Foreign PostalForeignAddress/ForeignPostalCd | Legal Domicile Foreign CountryLegalDomicileForeignCountryCd |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| THE CRITICAL PATH FOUNDATION | |||||||||||||||
| 1730 EAST RIVER ROAD SUITE 200 | TUCSON | AZ | 85718 | 204780896 | RAISING AND CONTRIBUTING FUNDS TO CRITICAL PATH INSTITUTE | AZ | 501(C)(3) | 11 | CRITICAL PATH INSTITUTE | Yes (1) | |||||
| CRITICAL PATH GLOBAL LTD | |||||||||||||||
| FACILITATE WORK WITH EUROPEAN MEDICINES AGENCY | CRITICAL PATH INSTITUTE | Yes (1) | 20-22 BEDFORD ROW | LONDON | UK | WC1R 4JS | UK | ||||||||
| Field | Value | IRS element (for citing) |
|---|---|---|
| Receipt Of Int Annts Rnts Rylts | 0 | ReceiptOfIntAnntsRntsRyltsInd |
| Gift Grnt Or Cap Contri To Oth Org | 0 | GiftGrntOrCapContriToOthOrgInd |
| Gift Grnt Cap Contri From Oth Org | 0 | GiftGrntCapContriFromOthOrgInd |
| Loans Or Guarantees To Other Org | 0 | LoansOrGuaranteesToOtherOrgInd |
| Loans Or Guarantees From Oth Org | 0 | LoansOrGuaranteesFromOthOrgInd |
| Div Related Organization | 0 | DivRelatedOrganizationInd |
| Asset Sale To Other Org | 0 | AssetSaleToOtherOrgInd |
| Asset Purchase From Other Org | 0 | AssetPurchaseFromOtherOrgInd |
| Asset Exchange | 0 | AssetExchangeInd |
| Rental Of Facilities To Oth Org | 0 | RentalOfFacilitiesToOthOrgInd |
| Rental Of Fclts From Oth Org | 0 | RentalOfFcltsFromOthOrgInd |
| Perform Of Services For Oth Org | 0 | PerformOfServicesForOthOrgInd |
| Perform Of Services By Other Org | 0 | PerformOfServicesByOtherOrgInd |
| Sharing Of Facilities | Yes (1) | SharingOfFacilitiesInd |
| Paid Employees Sharing | Yes (1) | PaidEmployeesSharingInd |
| Reimbursement Paid To Other Org | 0 | ReimbursementPaidToOtherOrgInd |
| Reimbursement Paid By Other Org | 0 | ReimbursementPaidByOtherOrgInd |
| Transfer To Other Org | 0 | TransferToOtherOrgInd |
| Transfer From Other Org | 0 | TransferFromOtherOrgInd |